Skip to main content
International Journal of Neuropsychopharmacology logoLink to International Journal of Neuropsychopharmacology
. 2023 Jul 11;26(8):584. doi: 10.1093/ijnp/pyad038

Corrigendum to: A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?

PMCID: PMC10464921  PMID: 37433025

This is a corrigendum to: João V Nani and others, A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?, International Journal of Neuropsychopharmacology, Volume 23, Issue 11, November 2020, Pages 721–730, https://doi.org/10.1093/ijnp/pyaa050

In the originally published online version of this manuscript, a grant number was missing from the Acknowledgments section. The Grant number to also be acknowledged for the paper is: “Grant Number: FAPESP 2014/50891-1”.

This error has been outlined in this corrigendum only to preserve the version of record.


Articles from International Journal of Neuropsychopharmacology are provided here courtesy of Oxford University Press

RESOURCES